PMGC (NASDAQ:ELAB) Posts Earnings Results

PMGC (NASDAQ:ELAB) announced its quarterly earnings data on Thursday. The company reported ($11.22) earnings per share for the quarter, FiscalAI reports. The firm had revenue of $0.68 million for the quarter.

PMGC Price Performance

Shares of ELAB traded up $0.02 during mid-day trading on Friday, reaching $2.08. 1,622,509 shares of the stock traded hands, compared to its average volume of 1,436,766. The firm has a fifty day moving average price of $3.70 and a 200 day moving average price of $41.87. The company has a current ratio of 1.74, a quick ratio of 1.72 and a debt-to-equity ratio of 0.01. The company has a market cap of $2.41 million, a price-to-earnings ratio of -0.01 and a beta of -0.27. PMGC has a 1 year low of $1.62 and a 1 year high of $309.12.

About PMGC

Elevai Labs, Inc, a skincare development company, designs, manufactures, and markets skincare products. Its products include Empower and Enfinity post-skincare procedure care serums for the face, neck, and upper chest regions. The company was formerly known as Reactive Medical Labs Inc and changed its name to Elevai Labs, Inc in December 2021. Elevai Labs, Inc was incorporated in 2020 and is based in Newport Beach, California.